Universal Health International Group Holding (HKSE:02211) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02211 Universal Health International Group Holding Ltd HKSE:02211
37 GF Score
Price HK$0.62
GF Value HK$0.29
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Universal Health International Group Holding Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Universal Health International Group Holding Valuation Rank Related Terms

HKSE:02211
37GF Score
Universal Health International Group Holding Ltd HKSE:02211
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Universal Health International Group Holding (HKSE:02211) Overvalued in 2026?

Based on GuruFocus' analysis, Universal Health International Group Holding stock appears to be overvalued. The current stock price of HK$0.62 is trading 113.8% above its estimated GF Value™ of HK$0.29. GuruFocus considers Universal Health International Group Holding to be Significantly Overvalued.

Key valuation signals for HKSE:02211:

  • Valuation Rank:
  • GF Value™: HK$0.29 vs. price of HK$0.62 (113.8% above fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02211 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universal Health International Group Holding Business Description

Address No. 14-1, Bei Yi Zhong Road, Tiexi District, Liaoning Province, Shenyang, CHN
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. The company operates its business through two segments: pharmaceutical retail and Distribution, (including import and export trade) include prescribed drugs, non-prescribed drugs (Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs), traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, etc. and majority of revnue comes from Distribution segment.
37GF Score

Get the complete analysis for HKSE:02211

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.62
Price
HK$0.29
GF Value